Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Antiphospholipid Syndrome
100%
Antiphospholipid Antibodies
50%
Recurrent Miscarriage
38%
Preeclampsia
36%
During Pregnancy
22%
Dermal Fillers
22%
Pregnant Women
21%
Hydroxychloroquine
20%
Autoimmune Disease
20%
Thrombosis
19%
Late-onset
17%
Immune-related Adverse Effects
16%
Lupus Anticoagulant
15%
Pregnancy Outcome
15%
Obstetric Complications
15%
Biomaterials
14%
European Registries
14%
Silicone
13%
Obstetric Outcomes
13%
Maternal Outcomes
13%
Autoimmune
13%
Angiogenic Factors
12%
Inflammatory Syndrome
12%
Adverse Reactions
12%
Miscarriage
12%
Fetal Loss
11%
Placental Growth Factor (PlGF)
11%
Soluble Fms-like Tyrosine kinase-1 (sFlt-1)
11%
Adverse Effects
10%
Cell-derived Microparticles
10%
Live Birth
9%
Immune-mediated Adverse Reactions
9%
Multicenter Retrospective Study
9%
Systemic Lupus Erythematosus
9%
Low Molecular Weight Heparin
9%
β2-glycoprotein I (β2GPI)
9%
Anticardiolipin
9%
Sydney
9%
Inflammatory Cytokines
9%
Antiphospholipid
8%
Regulatory T Cells
8%
Inflammatory Immune Response
8%
Fetus
8%
Hyaluronic Acid
8%
Low-dose Aspirin
8%
Selective Intrauterine Growth Restriction (sIUGR)
8%
Tumor Necrosis Factor-α
8%
Inherited Thrombophilia
8%
COVID-19
7%
Non-criteria
7%
Medicine and Dentistry
Antiphospholipid Syndrome
78%
Obstetrics
51%
Antiphospholipid Antibody
34%
Recurrent Miscarriage
32%
Pre-Eclampsia
29%
Autoimmune Disease
20%
Adverse Effect
19%
Hydroxychloroquine
17%
Adverse Event
15%
Systemic Lupus Erythematosus
14%
Pregnant Woman
14%
Retrospective Study
14%
Membrane Microparticle
13%
Systematic Review
13%
Prevalence
13%
Clinical Finding
13%
Thrombosis
12%
Spontaneous Abortion
12%
Disease
11%
Fetus Wastage
11%
Biocompatible Material
11%
Implant
10%
Lupus Anticoagulant
9%
Low Drug Dose
9%
Serositis
9%
Obstetric Complication
9%
Cytokine
8%
Acetylsalicylic Acid
8%
Fetus Growth
8%
Angiogenic Factor
8%
Antiangiogenic
8%
Intrauterine Growth Retardation
7%
Restylane
7%
Adjuvant
7%
Thrombophilia
7%
Autoimmunity
7%
Tumor Necrosis Factor
7%
Fetus Death
7%
Diseases
7%
Uterine Artery
6%
Therapeutic Management
6%
Autoimmune Rheumatic Disease
6%
Cyclosporine
6%
Immunomodulation
6%
Placental Growth Factor
6%
Lupus Erythematosus Panniculitis
6%
Birth Rate
6%
Bleeding
6%
Low Molecular Weight Heparin
6%
Granulomatosis
6%